Reisser C, Haberkorn U, Strauss L G
Hals-Nasen-Ohrenklinik, Universität Heidelberg.
HNO. 1992 Jun;40(6):225-31.
The metabolism of malignant tumours can be determined in vivo by positron emission tomography. Fifty patients with malignant lesions of the head and neck were examined before therapy and followed up for 11-18 months. The course of the disease was related to the initial fluorodeoxyglucose (FDG) uptake of the tumour. There was a relation between FDG uptake and survival: an increased FDG uptake of more than 300-400% was related to a reduced survival rate. Patients with an uptake less than 300% had a much better prognosis.
恶性肿瘤的代谢可通过正电子发射断层扫描在体内进行测定。50例头颈部恶性病变患者在治疗前接受了检查，并随访11 - 18个月。疾病进程与肿瘤最初的氟脱氧葡萄糖（FDG）摄取有关。FDG摄取与生存率之间存在关联：FDG摄取增加超过300 - 400%与生存率降低有关。摄取低于300%的患者预后要好得多。
